Xing Weirong R, Goodluck Helen, Zeng Canjun, Mohan Subburaman
Musculoskeletal Disease Center, Jerry L. Pettis Memorial VA Medical Center, Loma Linda, CA, USA; Department of Medicine, Loma Linda University, Loma Linda, CA, USA.
Musculoskeletal Disease Center, Jerry L. Pettis Memorial VA Medical Center , Loma Linda, CA, USA.
Bone Res. 2017 Mar 14;5:17003. doi: 10.1038/boneres.2017.3. eCollection 2017.
Leucine-rich repeat kinase 1 (LRRK1) plays a critical role in regulating cytoskeletal organization, osteoclast activity, and bone resorption with little effect on bone formation parameters. Deficiency of in mice causes a severe osteopetrosis in the metaphysis of the long bones and vertebrae bones, which makes LRRK1 an attractive alternative drug target for the treatment of osteoporosis and other high-turnover bone diseases. This review summarizes recent advances on the functions of the Lrrk1-related family members, deficiency-induced skeletal phenotypes, LRRK1 structure-function, potential biological substrates and interacting proteins, and the mechanisms of LRRK1 action in osteoclasts.
富含亮氨酸重复激酶1(LRRK1)在调节细胞骨架组织、破骨细胞活性和骨吸收方面发挥着关键作用,而对骨形成参数影响较小。小鼠体内LRRK1缺乏会导致长骨和椎骨干骺端出现严重的骨质石化,这使得LRRK1成为治疗骨质疏松症和其他高转换型骨疾病的一个有吸引力的替代药物靶点。本综述总结了LRRK1相关家族成员的功能、LRRK1缺乏诱导的骨骼表型、LRRK1的结构功能、潜在的生物学底物和相互作用蛋白,以及LRRK1在破骨细胞中的作用机制等方面的最新进展。